지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Objective: To evaluate the usefulness of serum concentrations of macrophage migration inhibitory factor (MIF) of patients with ovarian cysts for differential diagnosis of endometrioama. Method: From Jan. 2003 to Dec. 2004, preoperative serum MIF levels were assessed in 28 women with endometrioma, 32 with benign epithelial tumor, 23 with functional and simple cysts, 22 with benign mature cystic teratoma, and 25 women without ovarian tumor as control. MIF levels were determined using an ELISA (Quantikine Human MIF immunoassay, R&D Systems, Inc., USA). Results: Mean MIF levels were higher in all groups with benign tumors than control (all p<0.01), but there was no significant difference between benign tumor groups (p=0.95). There was no significant correlation between MIF levels and tumor volume, body mass index (BMI) (p=0.635, 0.674 respectively) Serum MIF level had significant correlation with count of WBC and neutrophils (p=0.008, 0.024 respectively), but had no correlation with count of lymhocytes and monocytes (p=0.688, 0.294 respectively). Conclusions: This study showed a marked increase in MIF concentrations in the peripheral blood of patients with endometrioma, but there was no significant difference with other benign tumors. Serum MIF level had significant correlation with count of WBC and neutrophils. These suggest serum MIF level has no usefulness for differential diagnosis of endometrioma from other benign ovarian cysts.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Serum Macrophage Migration Inhibitory Factor as a Biomarker of Active Pulmonary Tuberculosis
Annals of Laboratory Medicine
2018 .01
-
Hypertonic saline downregulate the production level of lipopolysaccharide-induced migration inhibitory factor in THP-1 cells
Annals of Surgical Treatment and Research
2012 .01
-
Macrophage Migration Inhibitory Factor: a Potential Marker for Cancer Diagnosis and Therapy
Asian Pacific journal of cancer prevention : APJCP
2012 .01
-
Levels of Macrophage Migration Inhibitory Factor (MIF) in Korean Patients with Atopic Dermatitis
천식 및 알레르기
2008 .01
-
혈중 대식세포 유주 저지 인자 측정을 위한 방사면역측정법
대한핵의학회지
2004 .01
-
혈중 MIF(Macrophage migration inhibitory factor) 측정을 위한 방사면역측정법
대한핵의학회 학술대회
2001 .01
-
류마티스관절염 활막세포에서 NF-κB 신호전달을 통한 MIF의 SDF-1 생성 유도
Immune Network
2007 .03
-
LPS 유도 생쥐 관절염에서 금은화의 MIF 활성 조절이 COX-2와 MMP-9 생성 억제에 미치는 영향
동의생리병리학회지
2010 .01
-
LPS 유도 생쥐 관절염에서 금은화의 MIF 활성 조절이 COX-2와 MMP-9 생성 억제에 미치는 영향
동의생리병리학회지
2010 .04
-
홍화자약침의 윤활관절막내에서의 MIF활성 억제를 통한 LPS 유발 관절염의 치료 효과
대한침구의학회지
2007 .01
-
Effect of Macrophage Migration Inhibitory Factor on Corneal Sensitivity after Laser In Situ Keratomileusis in Rabbit
Korean Journal of Ophthalmology
2014 .01
-
Macrophage 유주조지반응 및 MIF 측정법
대한수의사회지
1979 .01
-
Effect of hypertonic saline and macrophage migration inhibitory factor in restoration of T cell dysfunction
Annals of Surgical Treatment and Research
2011 .10
-
유근피(楡根皮) 약침이 lipopolysaccharide 유발 류마티스 관절염 모델에서 MIF 활성 억제에 미치는 영향
대한침구의학회지
2006 .01
-
Serum Anti-Müllerian Hormone Levels before Surgery in Patients with Ovarian Endometriomas Compared to Other Benign Ovarian Cysts
대한폐경학회지
2015 .01
-
자하차약침(紫河車藥鍼)의 MIF 활성 억제를 통한 LPS 유발 류마티스성 관절염의 치료 효과
대한침구의학회지
2008 .01
-
접골목(接骨木)추출물 및 약침액에 의한 MIF 활성 조절능이 생쥐의 제2형 Collagen 유발 관절염에 미치는 영향
대한침구의학회지
2012 .01
-
Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis
Pediatric Gastroenterology, Hepatology & Nutrition
2020 .01
-
Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study
Obstetrics & Gynecology Science
2013 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0